Cargando…

Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses

Detalles Bibliográficos
Autores principales:	Galiè, Nazzareno, Palazzini, Massimiliano, Manes, Alessandra
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930983/ https://www.ncbi.nlm.nih.gov/pubmed/20504865 http://dx.doi.org/10.1093/eurheartj/ehq152

Ejemplares similares

GPs Meet Rare Lung Disorders Task Force factsheet: pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2015)

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2009)

Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease
por: Palazzini, Massimiliano, et al.
Publicado: (2023)

A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension
por: Barozzi, Chiara, et al.
Publicado: (2019)

Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors
por: Dardi, Fabio, et al.
Publicado: (2023)

A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines
por: Dardi, Fabio, et al.
Publicado: (2021)

New horizons in pulmonary arterial hypertension therapies
por: Galiè, Nazzareno, et al.
Publicado: (2013)

Beyond the World Symposium on Pulmonary Hypertension: practical management of pulmonary arterial hypertension and evolving concepts
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

Pulmonary Arterial Hypertension: Combination Therapy in Practice
por: Burks, Marsha, et al.
Publicado: (2018)

The burden of comorbidities in pulmonary arterial hypertension
por: Lang, Irene M, et al.
Publicado: (2019)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

Future perspectives in pulmonary arterial hypertension
por: Simonneau, Gérald, et al.
Publicado: (2016)

A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013)

Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine
por: Parati, Gianfranco, et al.
Publicado: (2018)

Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting
por: van der Pol, Simon, et al.
Publicado: (2021)

Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19
por: Khan, Sikandar Hayat, et al.
Publicado: (2020)

BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
por: Evans, Jonathan D W, et al.
Publicado: (2016)

Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy?
por: Martin-Suarez, Sofia, et al.
Publicado: (2022)

The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets
por: Casucci, Gerardo, et al.
Publicado: (2020)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
por: Mahfoud, Felix, et al.
Publicado: (2020)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Does Regular Physical Activity Mitigate the Age-Associated Decline in Pulmonary Function?
por: Burtscher, Johannes, et al.
Publicado: (2022)

Interpreting troponin elevations: do we need multiple diagnoses?
por: Pierpont, Gordon L., et al.
Publicado: (2009)

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013)

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future
por: Mahfoud, Felix, et al.
Publicado: (2017)

The right ventricle in pulmonary arterial hypertension
por: Naeije, Robert, et al.
Publicado: (2014)

Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy
por: Burton, G.J., et al.
Publicado: (2009)

Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery
por: Sousa-Uva, Miguel, et al.
Publicado: (2014)

The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data
por: Buoli, Massimiliano, et al.
Publicado: (2017)

Challenges in pulmonary hypertension: managing the unexpected
por: Olsson, Karen M., et al.
Publicado: (2015)

4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle
por: Roberts, Bracken F., et al.
Publicado: (2017)

Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization
por: Sharman, James E., et al.
Publicado: (2017)

Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications
por: Gijsen, Frank, et al.
Publicado: (2019)

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
por: Zheng, Crystal, et al.
Publicado: (2020)

Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?
por: Edan, Gilles, et al.
Publicado: (2023)

Improving patient outcomes in pulmonary hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2015)

Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain–Barré Syndrome and Narcolepsy
por: Stowe, Julia, et al.
Publicado: (2019)

ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery
por: Thielmann, Matthias, et al.
Publicado: (2017)

An overview of the 6th World Symposium on Pulmonary Hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4rhrr59gmf9n8f452bjtmjgn9h